David Garcia is a seasoned sales specialist with extensive experience in the pharmaceutical industry, currently serving as a Cardiovascular and Renal Sales Specialist at Bayer since May 2021. In this role, David has led the product launch of Kerendia, focusing on its market share growth and educational outreach for patients with chronic kidney disease associated with type 2 diabetes. Prior to Bayer, David worked with The Janssen Pharmaceutical Companies of Johnson & Johnson, where key contributions included launching Spravato for Treatment Resistant Depression and Invokana, the first SGLT2 inhibitor for diabetes. Earlier positions included a Health Care Representative at Pfizer and a Diabetes Care Specialist at Novo Nordisk A/S. David's career commenced as a Branch Manager with Enterprise Rent-A-Car, reflecting a strong foundation in management and customer service. David holds a Bachelor's degree in Business Administration with a concentration in Accounting from Interamerican University of Puerto Rico.
This person is not in the org chart
This person is not in any teams
This person is not in any offices